Literature DB >> 12221462

The evaluation of graft irradiation as a method of preventing hemolysis after ABO-mismatched renal transplantation.

Hideki Ishida1, Kazunari Tanabe, Tadahiko Tokumoto, Hiroaki Shimmura, Hiroshi Toma.   

Abstract

Hemolysis may occur after organ transplantation. In most cases, hemolysis is drug-related, such as to cyclosporin, etc. However, it is important to consider graft-versus-host antibody formation as one of the causes of hemolysis. We evaluated the effect of local graft irradiation as a method of preventing hemolysis arising from ABO antibody formation after ABO-mismatched renal transplantations. The participants in this study were 44 patients who had undergone ABO-mismatched renal transplantation. Of these patients, 23 were subjected to postoperative local irradiation, and 21 were not. We examined the characteristics of anti-blood-type antibodies, and we also compared the frequency of the development of antibody formation and hemolysis development between the groups. The development rates of anti-ABO-antibody formation and hemolysis were significantly higher in the patients without local irradiation (15/21, 71%; 6/21, 29%) than in those with local irradiation (1/23, 4%; 0/23, 0%). The elevated antibodies mainly belonged to the IgG class, not the IgM class. The hemolysis- and antibody formation observed in the patients originally without postoperative local irradiation was dramatically improved by graft irradiation. Local graft irradiation after ABO-mismatched renal transplantations may be needed to prevent the formation of anti-ABO antibodies and to impede the development of hemolysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221462     DOI: 10.1007/s00147-002-0442-9

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  1 in total

1.  Alloimmune haemolysis in a renal transplant recipient receiving sirolimus.

Authors:  Adam J Hedley; Shaun Flint; Annabel Tuckfield; Rowan Walker; Solomon Cohney
Journal:  NDT Plus       Date:  2008-03-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.